Pharma Articles
Articles are written by renowned pharmaceutical company executives and other professionals from across the world on important topics relating to the business. The part of articles on the pharmaceutical industry focuses on current and developing concerns in fields such as pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical production, biopharmaceuticals, and information technology.
Strategic Partnerships and Collaborations in the European Pharmaceutical Industry
Pharma strategic partnerships are formal agreements in which two or more companies share resources risk and rewards to develop or commercialize medicines In Europe the main models are licensing codevelopment cocommercialization joint ventures and publicprivate consortia Companies choose based on how...
Strengthening Clinical Trials Through Digital and Decentralized Technologies
For most of the past halfcentury the clinical trial has been organised around the investigator site Participants travelled to hospitals data were recorded at the clinic and monitors travelled again to verify them That model produced the evidence behind modern medicine but it asks a great deal of the...
How AI Could Improve R&D Productivity Across the European Pharma Sector
Few industries invest in the future as heavily as European pharma According to the regions pharmaceutical industry federation the sector invested an estimated billion in research and development in Europe in making it the most researchintensive industry on the continent Yet boards increasingly con...
Ethical Standards and Responsible Decision-Making in the Pharmaceutical Industry
Picture this a new drug hits the market promising relief for millions But behind that promise lies a web of decisions about pricing clinical trial design marketing claims and data transparency
Oral Obesity Medicines: How Pills Could Change the European GLP-1 Market
For a decade the European obesity market has been defined by a needle a fridge and a specialist clinic In July that definition broke The European Commission granted marketing authorisation for a oncedaily mg oral semaglutide tablet making it the first GLP receptor agonist
Smart Quality Management: AI-Powered GMP Compliance and Release by Exception
European pharmaceutical manufacturing has rarely faced this many simultaneous pressures Tightened sterile expectations have raised the bar across the continents fillfinish capacity biosimilar competition is compressing biologics margins and procurement authorities are pushing
Biopharma M&A and Licensing: Strategic Partnerships Fueling Innovation
For much of the last decade acquisitions and licensing agreements were debated in European boardrooms as rival answers to the same question how to refill a pipeline faster than internal research alone allows That framing no longer holds In the most effective pharmaceutical companies run both instru...
The Rise of In Vivo Gene Editing: New Opportunities in Therapeutic Innovation
For most of the past decade genetic medicine has been defined by a logistical paradox The science was astonishing the operations were artisanal Cells were drawn from a patient flown to a specialist facility edited tested released and flown back for infusion after conditioning chemotherapy The result...
AI-Native Pharma: Redefining Enterprise Strategy Beyond Drug Discovery
For the better part of a decade artificial intelligence in pharma has been discussed almost entirely as a discovery story Boards have approved generative chemistry platforms protein structure prediction has moved from novelty to routine and the industry has grown comfortable describing AI as a way t...
Digital Bioprocessing: AI and Automation in Biologics Manufacturing
For most of the modern biologics era a mammalian cell culture batch was managed the way a ship is navigated in fog a fixed course periodic position checks and very little ability to correct midvoyage Operators set a feed strategy pulled offline samples once or twice a day and waited for the analytic...
